Tana T-12 Oral
The elderly may be more sensitive to the side effects of this drug, especially drowsiness and dizziness.
Children may be more sensitive to the side effects of this drug, especially unusual excitement.
This drug should not be used in newborns.
During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.
Based on information from related drugs, this medication may pass into breast milk. Therefore, breast-feeding while using this medication is not recommended. Consult your doctor before breast-feeding.
Tana T-12 Oral Drug Interactions
Your healthcare professionals (e.g., doctor or pharmacist) may already be aware of any possible drug interactions and may be monitoring you for it. Do not start, stop or change the dosage of any medicine before checking with them first.
Avoid taking MAO inhibitors (e.g., furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, selegiline, tranylcypromine) within 2 weeks before, during, and after treatment with this medication. In some cases a serious, possibly fatal, drug interaction may occur.
If you are currently using any of the medications listed above, tell your doctor or pharmacist before starting carbetapentane/chlorpheniramine.
Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use.
Tell your doctor or pharmacist if you also take drugs that cause drowsiness such as: certain other antihistamines (e.g., diphenhydramine), anti-seizure drugs (e.g., carbamazepine), medicine for sleep or anxiety (e.g., alprazolam, diazepam, zolpidem), muscle relaxants, narcotic pain relievers (e.g., codeine), psychiatric medicines (e.g., chlorpromazine, risperidone, amitriptyline, trazodone).
Check the labels on all your medicines (e.g., cough-and-cold products, allergy medications) because they may contain additional drowsiness-causing ingredients. Ask your pharmacist about the safe use of those products.
Previous Section
